Next Article in Journal
The Impact of Internet Development on Urban Eco-Efficiency—A Quasi-Natural Experiment of “Broadband China” Pilot Policy
Previous Article in Journal
Behavioral Changes, Adaptation, and Supports among Indonesian Female Sex Workers Facing Dual Risk of COVID-19 and HIV in a Pandemic
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Factors Associated with Urinary 1-Hydroxypyrene and Malondialdehyde among Adults near a Petrochemical Factory: Implications for Sex and Lifestyle Modification

1
Department of Family Medicine, Chang Gung Memorial Hospital, Chiayi 613, Taiwan
2
Department of Pulmonary Disease and Critical Care, Chang Gung Memorial Hospital, Yunlin 638, Taiwan
3
Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi 613, Taiwan
4
Department of Family Medicine, Chang Gung Memorial Hospital, Yunlin 638, Taiwan
5
Department of Laboratory Medicine, Chang-Gung Memorial Hospital, Linkou, Taoyuan 333, Taiwan
6
Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan 333, Taiwan
7
Department of Nursing, Chang Gung University of Science and Technology, Chiayi 613, Taiwan
8
School of Nursing, Chang Gung University, Taoyuan 333, Taiwan
9
Research Fellow, Department of Cardiology, Chang Gung Memorial Hospital, Chiayi 613, Taiwan
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(3), 1362; https://doi.org/10.3390/ijerph19031362
Submission received: 7 December 2021 / Revised: 15 January 2022 / Accepted: 22 January 2022 / Published: 26 January 2022

Abstract

:
Background: The association between the biomarkers of environmental exposure, oxidative stress, and health-related behaviors in community residents living in an endemic viral hepatitis area and near petrochemical industrial complexes remains unclear. From a health promotion perspective, healthcare providers must know what to do for residents concerned about their health and living environment, especially for individual-level and modifiable risk factors. Therefore, we aimed to explore the factors associated with urinary 1-hydroxypyrene (1-OHP) and malondialdehyde (MDA). Methods: A community-based, cross-sectional study was conducted between July 2018 and February 2019 in western coastal Yunlin County, Taiwan. All participants lived within a 10 km radius of a large petrochemical complex and did not work in the factory. This study was conducted with the local hospital through annual community health screening. Biological samples were collected and biomarkers determined and quantified in the central laboratory of the collaborating hospital. Results: A total of 6335 adult residents completed the study. The mean age was 47.7 (SD = 16) years. Out of the total population, 56.4% were female, 30.1% had metabolic syndrome (MetS), and 16.8% and 14.3% had hepatitis B virus antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) positivity, respectively. The median 1-OHP and MDA level was 0.11 and 0.9 μg/g creatinine with an interquartile range of 0.07–0.18, and 0.4–1.5, respectively. The MDA levels correlated with specific diseases. The multivariable ordinal logistic regression model revealed that female sex, smoking, betel nut use, HBsAg, and anti-HCV positivity were associated with higher 1-OHP levels. In men, MetS was associated with higher 1-OHP levels and regular exercise with lower 1-OHP levels. High MDA levels were associated with smoking, betel nut users, HBsAg, and anti-HCV positivity. Conclusions: The findings highlight the importance of initiating individualized health promotion programs for residents near petrochemical factories, especially for adults with substance-use and cardiometabolic risk factors. Furthermore, it is crucial to provide further treatment to patients with viral hepatitis.

1. Introduction

Previous studies have indicated that petrochemical industrial complexes (PICs) have a negative effect on human health and environment, especially during the manufacturing process [1,2,3]. In recent years, many entrepreneurs of PICs have positively advanced their company’s social responsibility by decreasing and controlling emissions during the production process. In addition, the government’s environmental regulation law approaches international criteria with a higher level of air pollution restriction [4]. Public health scholars continue to monitor air quality within a 10–40 km radius from the PICs in Taiwan [3,5,6]. Hence, from a health promotion perspective, frontline healthcare providers should focus on residents living around the PICs and monitor their health and living environment. Standing with people and making efforts to empower them with a focus on individual and family holistic wellbeing are our mission.
Many studies have indicated that PICs are a source of hazardous air pollutants through the production of polycyclic aromatic hydrocarbons (PAHs). They are associated with carcinogenic properties, respiratory problems, and kidney diseases among workers in petroleum refineries, coke ovens, and aluminum production [3,7,8]. The release of hazardous substances from PICs is also thought to increase the risk of cancer and chronic diseases among people living in the neighborhood [1,2,9,10]. Many studies have shown that PAHs are produced by the incomplete combustion of organic materials, and can be metabolized as 1-hydroxypyrene (1-OHP) and excreted through the feces and urine [2,3,11]. Urinary 1-OHP has been used to assess the amount of PAH exposure. 1-OHP levels are also significantly influenced by factors that include active or passive tobacco smoking, indoor air pollution, alcohol consumption, and cooking oil fumes produced by grilled or barbecued foods [5,12,13,14,15]. Little is known about the factors associated with urine 1-OHP levels among adult residents near PICs.
A previous study revealed that the positive correlation between urinary 1-OHP and lipid peroxidation biomarkers concentration. Hence, exposure to PAHs may lead to potential oxidative stress. [16,17]. Reactive oxygen species (ROS), such as oxygen, nitrogen, and sulfur, are highly reactive derivatives of oxygen metabolism and considered part of normal cellular metabolism. ROS plays a significant role in several signaling processes and can induce cellular damage or protection [18]. Oxidation metabolites are also known as oxidative stress biomarkers. Urine malondialdehyde (MDA) is produced after the reaction of ROS with polyunsaturated fatty acids, which contain abundant double bonds and are more susceptible to ROS [19,20,21]. Urine MDA is a frequently investigated oxidative stress marker for lipid peroxidation assessment [16,22]. Many studies have indicated that MDA is correlated with aging, cancer, liver diseases, chronic obstructive pulmonary disease, and cardiometabolic diseases [23,24,25]. Aging has also been proposed to play a prominent role in oxidative stress. The relationship between oxidative stress and disease pathogenesis has been widely discussed. For instance, excess ROS are mostly derived from mitochondrial dysfunction induced by metabolic disorder-related hyperglycemia; on the other hand, hyperglycemia causes mitochondrial overproduction of ROS via greater oxygen use [22]. ROS activate the pro-inflammatory signaling pathway, and the cytokine cascades induce endothelial cell dysfunction, foamy cell formation, vascular smooth muscle migration, and hyperplasia [16,26]. Serial reactions result in atheroma formation and further cardiometabolic diseases, such as hypertension, heart disease, stroke, and diabetes [16,27]. Increased oxidative stress plays a role in metabolic syndrome, aging, and the initiation and progression of atherosclerosis [13,19]. However, adopting a balanced diet is associated with the prevention of cardiometabolic diseases, through the reduction of inflammatory biomarkers [28].
The liver is the organ with the most active catabolism and contains abundant enzymes involved in redox reactions [20,29]. The liver is also the major site for PAH catabolism. The PAHs are converted to epoxide intermediates via cytochrome P450 catalysis and then turn into ultimate carcinogens [29]. Previous studies have indicated that viral hepatitis induces extensive oxidative stress. Oxidative stress plays a pivotal role in the progression of chronic hepatitis, through lipid peroxidation, DNA oxidation, protein oxidation, ROS production, and the subsequent triggering of carcinogenesis [23,29,30]. We hypothesized that urine 1-OHP and MDA are associated with an unhealthy lifestyle and chronic viral hepatitis due to inflammation. Previous studies have shown that the coastal city of Yunlin, Taiwan has a high prevalence of residents who engage in alcohol consumption, betel nut chewing, cigarette smoking, inadequate dietary adoption, and low exercise, and live around an endemic viral hepatitis region [31,32,33]. This phenomenon was because, five decades ago, many rural residents of Taiwan were treated with inadequately disinfected medical equipment while sick. For instance, they were given injections by unqualified physicians, which caused many innocent people to be unknowingly infected by HCV [32,33]. Therefore, the aim of this study was to explore the factors associated with urinary 1-OHP and MDA levels among adult residents near large PICs in central southwestern Taiwan.

2. Materials and Methods

2.1. Study Design and Population

We conducted a community-based, cross-sectional study between July 2018 and February 2019 in Yunlin County. All participants lived within a 10 km radius of a large petrochemical factory for many years. Considering the independent age and ability to participate in this study, the inclusion criteria were (1) area of residence in Mailiao and Taihsi designated townships; (2) more than 20 years of age and not working inside the PICs; (3) able to communicate in Mandarin or Taiwanese; (4) able to walk or drive to the local hospital and community health activity center; and (5) agreeing to participate in this study and signing the informed consent form. The exclusion criteria were an inability to answer questions or incomplete data.

2.2. Procedure and Ethical Approval

This study was approved by the institutional review board of the research ethics committee (No: IRB 201800428B0). It was conducted in collaboration with a local hospital through annual community health screening. All procedures were performed in accordance with the Helsinki Declaration. The township heads sent messages (oral and poster) regarding free health check-ups and invited individuals to participate in this study. Six nursing students were recruited as research assistants and trained by the investigators. The research team described the study procedures (e.g., collecting blood and urine specimens and an interview to track health-related habits with a questionnaire). The questionnaire consisted of health-related lifestyle behaviors, which were designed by the research team and based on previous studies [31,32]. Blood samples were drawn 8 h after fast; blood and urine samples were stored and sent to the central laboratory of the cooperating hospital.

2.3. Measurements

This study collected the following information via individual interviews and questionnaires along with the physiological biomarkers:
Demographic characteristics and health-related lifestyle behaviors, including sex, age, educational level (years), body height (cm), and body weight (kg). Participants were asked to report the frequency of seven health habits: (e.g., how often do you have…?): regular alcohol consumption (never vs. current or former user), betel nut chewing (never vs. current or former user), cigarette smoking (never vs. current or former smoker), at least three servings of vegetables (1.5 bowls) per day, two servings of fruit (1 bowl) per day, at least 1500 mL of water per day, and at least 30 min of exercise (3 times per week). The research team determined the frequencies of eating proper servings of vegetables/fruit/water and of adopting exercise as low (never/seldom) or often (usually/always).
Metabolic syndrome (MetS) and serum biomarkers: Based on the national standard [34], participants with the presence of three abnormal cardiometabolic risk factors, out of five, were classified as having MetS: (1) central obesity: waist circumference > 90/80 cm in males and females, measured between the last rib margin and the iliac crest; (2) systolic/diastolic blood pressure ≥ 130/85 mmHg; (3) high-density lipoprotein cholesterol < 40/50 mg/dL in males/females; (4) fasting blood glucose ≥ 100 mg/dL; (5) triglyceride level ≥ 150 mg/dL. Liver health information, including alanine aminotransferase (ALT > 35 U/L) and aspartate aminotransferase (AST > 35 U/L) levels, was used to detect liver inflammation status. Hepatitis B virus (surface antigen) and serum anti-hepatitis C virus (HCV) antibody (positive or negative) were used to identify viral hepatitis. Hepatitis B surface antigen (HBsAg) was analyzed by enzyme-linked immunosorbent assay (ELISA) using a SURASE B-96 plate (General Biological Corp., Hsinchu, Taiwan). Anti-HCV antibody was assessed by ELISA using an SP-NANBASE C-96 3.0 plate (General Biological Corp. Hsinchu, Taiwan).
Urine 1-OHP and MDA: Spot urine samples were collected and stored below −80 °C until urine 1-OHP and MDA levels were quantified in the central laboratory of the collaborating hospital. Both 1-OHP and MDA were expressed as μg/g CRE. Urinary 1-OHP was analyzed using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Urinary MDA was quantified using the standard thiobarbituric acid reactive substances (TBARS) assay. Urinary creatinine concentration was used for urinary 1-OHP and MDA adjustments.

2.4. Statistical Analyses

Because there were no reference values for urine 1-OHP and MDA concentrations, we equally divided the participants into quartiles according to 1-OHP and MDA levels. The demographics and characteristics among the MDA or 1-OHP quartiles were compared using one-way analysis of variance for continuous variables and a chi-square test for categorical variables, with a Bonferroni multiple comparison when the overall test was significant. The linear trend of the demographics and characteristics across the MDA or 1-OHP quartiles was also tested for linear contrast in a general linear model for continuous variables and the Cochran–Armitage test for categorical variables. Factors associated with higher levels of 1-OHP or MDA were investigated using a multivariable odds proportional model (ordinal logistic regression). The analysis was performed on the entire cohort and stratified by sex. MetS and body mass index (BMI) components were not included in the multivariable model due to collinearity with MetS. Laboratory data for liver function (AST and ALT) were also not entered into the multivariable model due to the collinearity with HBsAg and anti-HCV. Finally, the relationship between 1-OHP and MDA levels was examined using the Spearman’s rank correlation. All tests were two-tailed, and p < 0.05 was considered statistically significant. Data analyses were conducted using SPSS 25 (IBM SPSS Inc., Chicago, IL, USA).

3. Results

3.1. Participant Demographic Characteristics

A total of 6335 participants aged ≥ 20 years who completed the examination were included in the study, of whom 3574 (56.4%) were female. The mean age was 47.7 years, and the average education level was 9.6 years. Approximately half of the subjects (55.5%) were overweight or obese and MetS was prevalent in 30.1% of the population (n = 1909). Of note, 16.8% (n = 1067) and 14.3% (n = 909) of the subjects were identified as HBsAg and anti-HCV positive, respectively. The median 1-OHP level was 0.11 μg/g creatinine, with an interquartile range (IQR) of 0.07 to 0.18. The median MDA level was 0.9 μg/g creatinine, with an IQR of 0.4 to 1.5 (Table 1).
Compared to male subjects, females tended to have an older age, less education, lower prevalence of MetS, lower likelihood of substance use (smoking, alcohol drinking, and betel nut chewing), better dietary habits, and less exercise. Females also tended to have a lower prevalence of HBsAg and better liver function, but a higher potential for HCV infection. The results also showed that female subjects had slightly higher 1-OHP levels and slightly lower MDA levels than male subjects (Table 1). Additionally, the relationship between 1-OHP and MDA levels was examined (Figure 1). The results showed that the correlation was significantly positive, but weak (correlation coefficient = 0.09).

3.2. Factors Associated with 1-OHP Level

According to the quartiles of 1-OHP, Table 2 shows that there were significant differences in age, sex, education, BMI, MetS and its components (except waist circumference), substance use, dietary habits, regular exercise, HBsAg, anti-HCV, and liver function. Based on the multivariable ordinal logistic regression model, Table 3 demonstrates that older age (odds ratio (OR) 0.97, 95% confidence interval (CI) 0.96–0.98) and a higher education level (OR 0.96, 95% CI 0.95–0.97) were associated with a lower 1-OHP level. In contrast, several factors were identified to be associated with a higher 1-OHP level, including female (OR 2.30, 95% CI 2.06–2.57), smoking (OR 6.94, 95% CI 5.96–8.08), betel nut chewing (OR 1.25, 95% CI 1.04–1.52), HBsAg (OR 1.27, 95% CI 1.12–1.43), and anti-HCV positivity (OR 1.43, 95% CI 1.12–1.43). After stratifying the analysis by sex, the results revealed that MetS was associated with a higher 1-OHP level in male subjects (OR 1.17, 95% CI 1.00–1.36) but not in female subjects. In addition, an association between frequent regular exercise and lower 1-OHP levels was observed only in male participants.

3.3. Factors Associated with MDA Level

Based on the MDA level quartiles, Table 4 shows that there were significant differences in age, sex, education, BMI, MetS and its components, substance use, dietary habit of vegetable (but not fruit) consumption, both types of hepatitis, and liver function. Based on the multivariable ordinal logistic regression model, Table 5 demonstrated that older age (OR 1.02, 95% CI 1.01–1.02), smoking (OR 1.32, 95% CI 1.15–1.51), betel nut chewing (OR 1.22, 95% CI 1.02–1.45), HBsAg (OR 1.25, 95% CI 1.11–1.41), and anti-HCV positivity (OR 1.48, 95% CI 1.29–1.70) were associated with a higher MDA level. In contrast, a higher education level was associated with a lower MDA level (OR 0.98, 95% CI 0.97–0.99). After stratifying the analysis by sex, the results were generally consistent between male and female participants. The effect of smoking and betel nut chewing in male subjects was more apparent because the prevalence of betel nut chewing was higher in men.

4. Discussion

Our results provide important data for further study and evidence-based lifestyle modifications. This study had three important findings. First, smoking, betel nut chewing, HBsAg, and anti-HCV positivity were significantly associated with higher urinary concentrations of 1-OHP and MDA. Second, a high prevalence of cardiometabolic risk factors and chronic viral hepatitis was found in this population. Third, sex differences were found in adopting unhealthy lifestyles, and men tended to show substance use and inadequate diet, while females tended to take less regular exercise.
The present findings strongly indicate an association between smoking and urinary 1-OHP concentration, with an odds ratio of 6.94, which was statistically significant in women and men, and is in agreement with the findings of previous studies [12,13,35,36]. This is not surprising, because each cigarette contains 3.2–16.0 ng benzo(a)pyrene [37]. A substantial amount of evidence supports the suggestion that active or passive cigarette smoking-related oxidative stress causes inflammation, which in turn results in further generation of ROS and potentially increases oxidative damage to macromolecular targets that may lead to cancer initiation and/or progression [35,38]. This also explains why smokers tended to have higher urinary MDA levels, with an odds ratio of 1.32. The betel nut (also called areca) has been confirmed as a class I carcinogen and is a popular addictive substance in Asia [31]. Furthermore, some studies have confirmed that areca nut extract and other areca ingredients can induce ROS in oral epithelial cells, which may involve oxidative stress via redox imbalance [39]. Our study revealed that betel nut users had higher 1-OHP and MDA concentrations, with 1.25 and 1.22 odds ratios, respectively. This implies that the influence of betel nut-induced oxidative stress may not be confined to the oral cavity. Notably, previous studies found that cigarette smokers also tended to have betel nut-chewing and alcohol-drinking habits in this study area [31]. The present finding also indicates that education level was significantly associated with lower 1-OHP and MDA levels. A higher education level may enable individuals to adopt healthier lifestyles, including having a balanced diet, less substance use, and more regular exercise. Therefore, further studies are needed to initiate smoking and betel nut cessation programs, especially for community adults with lower socioeconomic status.
Theoretically, adopting adequate exercise and consuming fruits or vegetables rich in dietary antioxidants vitamin C, vitamin E, and carotenoids may lower oxidative stress and result in lower 1-OHP and MDA biomarker levels, as supported by the findings of many studies [12,28]. However, this benefit was not consistent with the findings of the present study. This could be because nutrients were quantified using a simple questionnaire, which might have caused a distortion of the real data or the dietary amount. Studies have shown that it is difficult to demonstrate the benefits of nutrient intervention in nutrient-deficient populations [20]. Therefore, it may not be feasible to manage low oxidative stress therapy using nutrient supplements. The present findings show that adopting regular exercise in male adults resulted in significant benefits in lowering 1-OHP concentration, with an odds ratio of 0.8, but did not influence the MDA biomarker. Hence, quantitation of specific types of exercise and diets should be clarified in further studies, to determine the most effective practices for relieving oxidative stress.
According to a report from the Nutrition and Health Survey in Taiwan (NAHSIT) 2005–2008, the prevalence of adult MetS was 25.5% and increased from 13.6% in NAHSIT 1993–1996 [34]. The present study demonstrated that 30.1% of the participants had MetS and 55.5% were overweight or obese, and these frequencies were significantly higher than those observed nationwide and in Asian regions [40]. Since ROS can initiate the inflammatory signaling pathway, in which cytokines induce endothelial cell dysfunction, the serial reactions would result in atheroma formation and other cardiometabolic diseases [22,27]. Hence, fundamental prevention strategies should focus on reducing MetS and cardiometabolic risks through lifestyle modification, while considering sex differences [41]. For instance, we should empower male adults to adopt a healthier diet, with sufficient servings of vegetables and fruit, and female adults to perform regular exercise.
The current prevalence of HCV infection in Taiwan is approximately 4% [42]. A high prevalence of viral hepatitis was noted in the present study. This may be related to an incident which happened a few decades ago, where blood-borne virus transmission was caused by inadequate sterilization of medical equipment, or infection by unscreened blood products in Taiwan, specifically in the southwestern coastal area [42,43]. Previous studies have indicated that oxidative stress, viral hepatitis, and liver cancer may be interconnected [23,29]. HCV has evolved to manipulate pro- and antioxidant balance and generate sustainable oxidative stress that not only causes hepatic damage but also stimulates processes that reduce damage treatment. Lipid metabolism pathways present a clear danger to the accumulation of viral-induced ROS. These disorders tend to lead to cirrhosis and hepatocellular carcinoma (HCC), but there is little real-world data confirmation. Our large-scale data verified this theory and demonstrated that viral hepatitis carriers are prone to higher levels of 1-OHP and MDA, especially chronic hepatitis C carriers. Oxidative stress may trigger HCC in patients with chronic viral hepatitis [20,30]. Therefore, oxidative biomarker assessment may provide us with a better understanding of disease history and progress beyond traditional laboratory studies. Fortunately, the WHO has launched a global health strategy to eliminate hepatitis C by 2030 [30,43], and the Taiwanese government has implemented an elimination goal, with free antiviral treatment by National Health Insurance [42,44]. Recently, the emergence of direct-acting antivirals, such as asunaprevir/daclatasvir, has increased cure rates and treatment safety, with more than 95% efficiency, few adverse effects, and a short treatment time of 8–12 weeks [44,45]. Many adults near the PICs with chronic viral hepatitis do not receive the much-needed available information [32]. Therefore, it is crucial for us to recommend both HBV and HCV carriers for further antiviral treatment.
Compared with females, male sex was significantly associated with a higher prevalence of smoking, alcohol consumption, and betel nut chewing, and tended to also be associated with more regular exercise but improper diet habits, in agreement with published findings [31,33]. The present findings showed that the prevalence of current or former female smokers was only 4.5%, and this rate was lower than that of males (40.5%). However, the female sex was associated with significantly higher levels of urinary 1-OHP. This result is consistent with those of previous studies [8,11,12]. This could be due to the amount of time women spend in the kitchen, and cooking methods with frying and high temperatures can produce cooking oil fumes. In addition, poorly ventilated kitchens may increase fume inhalation [13,41]. The 1-OHP is a sensitive biomarker that reflects indoor air pollutant exposure [15]. Exposure to cooking oil fumes can lead to disturbed cardiovascular autonomic function and an increased risk of oxidative DNA injury [5]. Furthermore, numerous studies have reported an increase in the incidence of cardiovascular and respiratory diseases among women and children who lived around smokers [46,47]. As a cohort study in the United States, Gearhart-Serna et al. [36] indicated that smoking and secondhand smoke exposure accounted for the largest PAH intake, and that there were strong interactions between race/ethnicity and smoking or second-hand smoke, especially in vulnerable populations for high PAH exposure. From the perspectives of human and environmental health, it is necessary to conduct a tailored health promotion program, including strategies to reduce cooking oil fumes by improving ventilation devices and methods to avoid secondhand smoke. In addition, it is time to initiate more aggressive actions in the smoking cessation program and regulation for the vulnerable group near the PICs.
There are some limitations to this study. First, the limited geographical scope might limit the generalizability of the findings. Second, the health-related behavior assessments were mostly self-reported and were not measured more precisely, for example, water or vegetable intake, although we demonstrated servings with a standardized container. Third, due to the lack of information on the history of medications used for hypertension or diabetes, an underestimation of the prevalence of cardiometabolic risks might have occurred.

5. Conclusions

This study used large-scale data to explore the association between the biomarkers of environmental exposure, oxidative stress, and health-related behaviors in community residents living in an endemic area of viral hepatitis and nearby large PICs. A high prevalence of cardiometabolic risk factors and chronic viral hepatitis was found in this population. Furthermore, smoking, betel nut use, HBsAg, and anti-HCV positivity were associated with higher urinary 1-OHP and MDA levels. The findings highlight the importance of initiating individualized health promotion programs for adult residents, including cardiometabolic risk prevention, and smoking and betel-nut cessation, and regulations to avoid second-hand smoke. In addition, there is an urgent need to provide antiviral treatment to residents with chronic hepatitis.

Author Contributions

C.-H.H., T.-J.H., and M.-Y.C. contributed to conception and study design; C.-H.H., T.-J.H., and Y.-C.L. contributed to acquisition of data; M.-Y.C. and C.-N.L. performed data analysis; M.-Y.C. and C.-N.L. contributed to interpretation of data; C.-H.H. and M.-Y.C. contributed to manuscript writing. All authors have read and agreed to the published version of the manuscript.

Funding

The study was supported by a grant from Taiwan Formosa Plastic Group (FCRP F6L0011) and Chang Gung Memorial Hospital (NMRPF6H0043).

Institutional Review Board Statement

Ethical approval was obtained from the Institutional Review Board (IRB NO: 201800428B0) at the Chang Gung Memorial Hospital Foundation, Taiwan. All participants gave informed written consent to participate and were informed that they were free to withdraw from the study at any time.

Informed Consent Statement

Not applicable.

Data Availability Statement

The individual-level data used and/or analyzed for the current study are available from the corresponding author on request.

Acknowledgments

We would like to thank all the participants of this study and all staff at the Chang Gung Memorial Hospital, Yunlin Branch, for their support in making this study possible.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

PICs: petrochemical industrial complexes; 1-OHP, 1-hydroxypyrene; MDA, malondialdehyde; MetS, metabolic syndrome; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; WC, waist circumference; ROS, reactive oxygen species; TBARs, thiobarbituric acid reactive substances; IQR, inter-quartile range.

References

  1. Chang, W.W.; Boonhat, H.; Lin, R.T. Incidence of respiratory symptoms for residents living near a petrochemical industrial complex: A meta-analysis. Int. J. Environ. Res. Public Health 2020, 17, 2474. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Domingo, J.L.; Marquès, M.; Nadal, M.; Schuhmacher, M. Health risks for the population living near petrochemical industrial complexes. Cancer risks: A review of the scientific literature. Environ. Res. 2020, 186, 109495. [Google Scholar] [CrossRef] [PubMed]
  3. Yuan, T.H.; Ke, D.Y.; Wang, J.E.; Chan, C.C. Associations between renal functions and exposure of arsenic and polycyclic aromatic hydrocarbon in adults living near a petrochemical complex. Environ. Pollut. 2020, 256, 113457. [Google Scholar] [CrossRef] [PubMed]
  4. Environmental Protection Administration, EPA. Environmental White Paper-2020. Available online: https://www.epa.gov.tw/Page/3CFBDA8551D7D8E5 (accessed on 15 August 2021).
  5. Chan, C.C.; Lin, L.Y.; Lai, C.H.; Chuang, K.J.; Wu, M.T.; Pan, C.H. Association of particulate matter from cooking oil fumes with heart rate variability and oxidative stress. Antioxidants 2021, 10, 1323. [Google Scholar] [CrossRef]
  6. Lin, C.K.; Hung, H.Y.; Christiani, D.C.; Forastiere, F.; Lin, R.T. Lung cancer mortality of residents living near petrochemical industrial complexes: A meta-analysis. Environ. Health 2017, 16, 101. [Google Scholar] [CrossRef] [Green Version]
  7. Patel, A.P.; Mehta, S.S.; White, A.J.; Niehoff, N.M.; Arroyave, W.D.; Wang, A. Urinary polycyclic aromatic hydrocarbon metabolites and mortality in the United States: A prospective analysis. PLoS ONE 2021, 16, e0252719. [Google Scholar] [CrossRef]
  8. Tombolini, F.; Pigini, D.; Tranfo, G.; Paci, E.; Carosi, I.; Marini, F. Levels of urinary metabolites of four PAHs and cotinine determined in 1016 volunteers living in central Italy. Environ. Sci. Pollut. Res. Int. 2018, 25, 28772–28779. [Google Scholar] [CrossRef]
  9. Fedeli, U.; Girardi, P.; Mastrangelo, G. Occupational exposure to viny chloride and liver diseases. World J. Gastroenterol. 2019, 25, 4885–4891. [Google Scholar] [CrossRef]
  10. Jephcote, C.; Brown, D.; Verbeek, T.; Mah, A. A systematic review and meta-analysis of haematological malignancies in residents living near petrochemical facilities. Environ. Health 2020, 19, 53. [Google Scholar] [CrossRef]
  11. Keir, J.L.A.; Cakmak, S.; Blais, J.M.; White, P.A. The influence of demographic and lifestyle factors on urinary levels of PAH metabolites-empirical analyses of cycle 2 (2009–2011) CHMS data. J. Expo. Sci. Environ. Epidemiol. 2021, 31, 386–397. [Google Scholar] [CrossRef] [Green Version]
  12. Hoseini, M.; Nabizadeh, R.; Delgado-Saborit, J.M.; Rafiee, A.; Yaghmaeian, K.; Parmy, S. Environmental and lifestyle factors affecting exposure to polycyclic aromatic hydrocarbons in the general population in a Middle Eastern area. Environ. Pollut. 2018, 240, 781–792. [Google Scholar] [CrossRef] [PubMed]
  13. Jain, R.B. Contributions of dietary, demographic, disease, lifestyle and other factors in explaining variabilities in concentrations of selected monohydroxylated polycyclic aromatic hydrocarbons in urine: Data for US children, adolescents, and adults. Environ. Pollut. 2020, 266, 115178. [Google Scholar] [CrossRef] [PubMed]
  14. Singh, A.; Kamal, R.; Ahamed, I.; Wagh, M.; Bihari, V.; Sathian, B. PAH exposure-associated lung cancer: An updated meta-analysis. Occup. Med. 2018, 68, 255–261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Senerat, A.M.; Manemann, S.M.; Clements, N.S.; Brook, R.D.; Hassett, L.C.; Roger, V.L. Biomarkers and indoor air quality: A translational research review. J. Clin. Transl. Sci. 2020, 5, e39. [Google Scholar] [CrossRef] [PubMed]
  16. Barrera, G.S.; Pizzimenti, M.; Daga, C.; Dianzani, A.; Arcaro, G.P.; Cetrangolo, G. Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants 2018, 7, 102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Zhu, H.; Martinez-Moral, M.P.; Kannan, K. Variability in urinary biomarkers of human exposure to polycyclic aromatic hydrocarbons and its association with oxidative stress. Environ. Int. 2021, 156, 106720. [Google Scholar] [CrossRef]
  18. Akanji, M.A.; Rotimi, D.E.; Elebiyo, T.C.; Awakan, O.J.; Adeyemi, O.S. Redox homeostasis and prospects for therapeutic targeting in neurodegenerative disorders. Oxid. Med. Cell Longev. 2021, 2021, 9971885. [Google Scholar] [CrossRef]
  19. Masarone, M.; Rosato, V.; Dallio, M.; Gravina, A.G.; Aglitti, A.; Loguercio, C. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid. Med. Cell Longev. 2018, 2018, 9547613. [Google Scholar] [CrossRef]
  20. Uchida, D.; Takaki, A.; Oyama, A.; Adachi, T.; Wada, N.; Onishi, H. Oxidative stress management in chronic liver diseases and hepatocellular carcinoma. Nutrients 2020, 12, 6. [Google Scholar] [CrossRef]
  21. Wang, J.H.; Lee, S.B.; Lee, D.S.; Son, C.G. Total antioxidant capacity in HBV carriers, a promising biomarker for evaluating hepatic fibrosis: A pilot study. Antioxidants 2021, 10, 77. [Google Scholar] [CrossRef]
  22. Yuan, T.; Yang, T.; Chen, H.; Fu, D.; Hu, Y.; Wang, J. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019, 20, 247–260. [Google Scholar] [CrossRef] [PubMed]
  23. Alavian, S.M.; Showraki, A. Hepatitis B and its relationship with oxidative stress. Hepat. Mon. 2016, 16, e37973. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Paliogiannis, P.G.; Fois, A.G.; Sotgia, S.; Mangoni, A.A.; Zinellu, E.; Pirina, P. Circulating malondialdehyde concentrations in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Biomark. Med. 2018, 12, 771–781. [Google Scholar] [CrossRef] [PubMed]
  25. Pinna, A.; Boscia, F.; Paliogiannis, P.; Carru, C.; Zinellu, A. Malondialdehyde levels in patients with age-related macular degeneration: A systematic review and meta-analysis. Retina 2020, 40, 195–203. [Google Scholar] [CrossRef]
  26. Yegorov, Y.E.; Poznyak, A.V.; Nikiforov, N.G.; Sobenin, I.A.; Orekhov, A.N. The link between chronic stress and accelerated aging. Biomedicines 2020, 8, 198. [Google Scholar] [CrossRef]
  27. Poznyak, A.; Grechko, A.; Poggio, P.; Myasoedova, V.A.; Alfieri, V.; Orekhov, A.N. The diabetes mellitus-atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation. Int. J. Mol. Sci. 2020, 21, 1835. [Google Scholar] [CrossRef] [Green Version]
  28. Ahmad, S.; Moorthy, M.; Demler, O.V.; Hu, F.B.; Ridker, P.M.; Chasman, D.I. Assessment of risk factors and biomarkers associated with risk of cardiovascular disease among women consuming a Mediterranean diet. JAMA Netw. Open 2018, 1, e185708. [Google Scholar] [CrossRef] [Green Version]
  29. Elpek, G.O. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World J. Clin. Cases 2021, 9, 4890–4917. [Google Scholar] [CrossRef]
  30. Ivanov, A.V.; Valuev-Elliston, V.T.; Tyurina, D.A.; Ivanova, O.N.; Kochetkov, S.N.; Bartosch, B. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget 2017, 8, 3895–3932. [Google Scholar] [CrossRef] [Green Version]
  31. Guo, S.E.; Huang, T.J.; Lin, M.S.; Huang, R.M.; Chang, C.H.; Chen, M.Y. Alcohol, betel nut, and cigarette consumption are negatively associated with health promoting behaviors in Taiwan: A cross sectional study. BMC Public Health 2013, 13, 257. [Google Scholar] [CrossRef] [Green Version]
  32. Li, W.; Chang, T.S.; Chang, S.Z.; Chen, C.H.; Chen, M.Y. Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: A success story of the interdisciplinary collaboration approach. BMC Infect. Dis. 2020, 20, 737. [Google Scholar] [CrossRef] [PubMed]
  33. Lin, Y.C.; Chiu, W.; Chang, T.S.; Huang, T.J.; Chen, M.Y. Liver health literacy and health status among adults with hepatitis C: Implications for the nursing profession as part of the 2030 global elimination goal. J. Nurs. Scholarsh. 2019, 52, 128–135. [Google Scholar] [CrossRef] [PubMed]
  34. Health Promotion Administration, HPA. Metabolic Syndrome. Available online: https://www.hpa.gov.tw/Pages/List.aspx?nodeid=359 (accessed on 1 January 2021).
  35. Caliri, A.W.; Tommasi, S.; Besaratinia, A. Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat. Res. 2021, 787, 108365. [Google Scholar] [CrossRef] [PubMed]
  36. Gearhart-Serna, L.M.; Tacam, M., Jr.; Slotkin, T.A.; Devi, G.R. Analysis of polycyclic aromatic hydrocarbon intake in the US adult population from NHANES 2005-2014 identifies vulnerable subpopulations, suggests interaction between tobacco smoke exposure and sociodemographic factors. Environ. Res. 2021, 201, 111614. [Google Scholar] [CrossRef]
  37. Ding, Y.S.; Ward, J.; Hammond, D.; Watson, C.H. Mouth-level intake of benzo[a]pyrene from reduced nicotine cigarettes. Int. J. Environ. Res. Public Health 2014, 11, 11898–11914. [Google Scholar] [CrossRef] [Green Version]
  38. Zhou, B.; Ma, Y.; Wei, F.; Zhang, L.; Chen, X.; Peng, S. Association of active/passive smoking and urinary 1-hydroxypyrene with poor sleep quality: A cross-sectional survey among Chinese male enterprise workers. Tob. Induc. Dis. 2018, 16, 23. [Google Scholar] [CrossRef]
  39. Chen, I.C.; Chiang, W.F.; Chen, P.F.; Chiang, H.C. STRESS-responsive deacetylase SIRT3 is up-regulated by areca nut extract-induced oxidative stress in human oral keratinocytes. J. Cell Biochem. 2014, 115, 328–339. [Google Scholar] [CrossRef]
  40. Ranasinghe, P.; Mathangasinghe, Y.; Jayawardena, R.; Hills, A.P.; Misra, A. Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: A systematic review. BMC Public Health 2017, 17, 101. [Google Scholar] [CrossRef] [Green Version]
  41. Lechner, K.; von Schacky, C.; McKenzie, A.L.; Worm, N.; Nixdorff, U.; Lechner, B. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors. Eur. J. Prev. Cardiol. 2020, 7, 394–406. [Google Scholar] [CrossRef] [Green Version]
  42. Taiwan Medical Association, TMA. Hepatitis C Epidemiology and Prevention Strategy. Available online: http://www.fma.org.tw/2016/I-1-3.html/ (accessed on 20 May 2020).
  43. World Health Organization. Fact Sheet: Hepatitis C. Available online: http://www.who.int/newsroom/fact-sheets/detail/hepatitis-c/ (accessed on 15 May 2020).
  44. National Health Insurance, NHI. Hepatitis C Full Oral New Drug Health Insurance Payment Implementation Plan. Available online: https://www.nhi.gov.tw/Content_List.aspx?n=A4EFF6CD1C4891CA&topn=3FC7D09599D25979 (accessed on 25 May 2021).
  45. Wu, P.S.; Chang, T.S.; Lu, S.N.; Chang, S.Z.; Su, H.J.; Chen, M.Y. An investigation of the side effects, patient feedback, and physiological changes associated with direct-acting antiviral therapy for hepatitis C. Int. J. Environ. Res. Public Health 2019, 16, 4981. [Google Scholar] [CrossRef] [Green Version]
  46. Chen, M.Y. The negative impact of parental smoking on adolescents’ health- promoting behaviors: A cross-sectional study. Int. J. Environ. Res. Public Health 2021, 18, 2514. [Google Scholar] [CrossRef] [PubMed]
  47. Sharma, T.; Khapre, M. Exposure of secondhand smoke in women and children: A narrative review. J. Family Med. Prim. Care 2021, 10, 1804–1807. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Relationship between MDA and 1-OHP levels. MDA, malondialdehyde; 1-OHP, 1-hydroxypyrene.
Figure 1. Relationship between MDA and 1-OHP levels. MDA, malondialdehyde; 1-OHP, 1-hydroxypyrene.
Ijerph 19 01362 g001
Table 1. Demographic characteristics of the study subjects according to gender (N = 6335).
Table 1. Demographic characteristics of the study subjects according to gender (N = 6335).
VariableTotal
(N = 6335)
Female
(n = 3574)
Male
(n = 2761)
p-Value
Age, year47.7 ± 16.147.9 ± 16.247.3 ± 16.00.109
Education level, years9.6 ± 5.88.8 ± 6.210.7 ± 4.9<0.001
Body mass index ≥ 24 kg/m23518 (55.5)1672 (46.8)1846 (66.9)<0.001
Metabolic syndrome (MetS)1909 (30.1)980 (27.4)929 (33.6)<0.001
No. of MetS components1.74 ± 1.391.59 ± 1.421.93 ± 1.33<0.001
Each component of MetS
  SBP/DBP ≥ 130/85 mmHg3468 (54.7)1703 (47.6)1765 (63.9)<0.001
  Waist circumference 12636 (41.6)1518 (42.5)1118 (40.5)0.113
  FBG ≥ 100 mg/dL2217 (35.0)1096 (30.7)1121 (40.6)<0.001
  HDL-C < 40/50 (M/F) mg/dL778 (12.3)210 (5.9)568 (20.6)<0.001
 Triglyceride ≥ 150 mg/dL1213 (19.1)460 (12.9)753 (27.3)<0.001
Smoking <0.001
  Never 5055 (79.8)3412 (95.5)1643 (59.5)
  Current/Quit 1280 (20.2)162 (4.5)1118 (40.5)
Alcoholic drinking <0.001
  Never5520 (87.1)3472 (97.1)2048 (74.2)
  Current/Quit 815 (12.9)102 (2.9)713 (25.8)
Betel nut chewing <0.001
  Never5699 (90.0)3544 (99.2)2155 (78.1)
  Current/Quit 636 (10.0)30 (0.8)606 (21.9)
Intake vegetables <0.001
  Never/Seldom2144 (33.8)1056 (29.5)1088 (39.4)
  Often4191 (66.2)2518 (70.5)1673 (60.6)
Intake fruit <0.001
  Never/Seldom3512 (55.4)1823 (51.0)1689 (61.2)
  Often2823 (44.6)1751 (49.0)1072 (38.8)
Adopt regular exercise <0.001
  Never/Seldom4392 (69.3)2593 (72.6)1799 (65.2)
  Often1943 (30.7)981 (27.4)962 (34.8)
HBsAg1067 (16.8)528 (14.8)539 (19.5)<0.001
Anti-HCV909 (14.3)553 (15.5)356 (12.9)0.004
AST > 35 U/L653 (10.3)277 (7.8)376 (13.6)<0.001
ALT > 35 U/L1362 (21.5)461 (12.9)901 (32.6)<0.001
1-OHP, μg/g CRE0.11 [0.07, 0.18]0.11 [0.07, 0.17]0.10 [0.06, 0.19]0.015
MDA, μg/g CRE0.90 [0.40, 1.50]0.90 [0.40, 1.50]1.00 [0.50, 1.50]0.034
Abbreviations: MetS, metabolic syndrome; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; M, male; F, female; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; AST, aspartate aminotransferase; ALT, alanine aminotransferase; 1-OHP, 1-hydroxypyrene; CRE, creatinine; MDA, malondialdehyde; 1 Waist circumference, male > 90 cm and female > 80 cm; data are presented as frequency (percentage), mean ± standard deviation or median [25th, 75th percentile].
Table 2. Factors associated with the quartiles of urine 1-OHP concentration level (N = 6335).
Table 2. Factors associated with the quartiles of urine 1-OHP concentration level (N = 6335).
VariableQ1
(n = 1864)
Q2
(n = 1483)
Q3
(n = 1462)
Q4
(n = 1526)
p-Valuep Trend
Level, μmol/g CRE 1≤0.070.07–0.110.11–0.18>0.18
Age, year50.7 ± 17.247.3 ± 16.4 a46.1 ± 15.8 a45.8 ± 14.2 a<0.001<0.001
Female946 (50.8)874 (58.9) a956 (65.4) a,b798 (52.3) b,c<0.0010.014
Education level, years9.4 ± 6.39.9 ± 6.09.7 ± 5.79.4 ± 5.00.0640.867
BMI ≥ 24 kg/m21079 (57.9)828 (55.8)767 (52.5) a844 (55.3)0.0200.035
MetS581 (31.2)433 (29.2)412 (28.2)483 (31.7)0.1170.970
Each component of MetS1.83 ± 1.391.66 ± 1.38 a1.66 ± 1.38 a1.78 ± 1.410.0010.335
Each MetS component
  SBP/DBP ≥ 130/85 mmHg1162 (62.3)788 (53.1) a753 (51.5) a765 (50.1) a<0.001<0.001
  WC 1749 (40.2)633 (42.7)613 (41.9)641 (42.0)0.4890.335
  FBG ≥ 100 mg/dL732 (39.3)499 (33.6) a456 (31.2) a530 (34.7) a<0.0010.001
  HDL-C < 40/50(M/F) mg/dL216 (11.6)147 (9.9)157 (10.7)258 (16.9) a,b,c<0.001<0.001
  TG ≥ 150 mg/dL352 (18.9)234 (15.8)261 (17.9)366 (24.0) a,b,c<0.001<0.001
Smoking <0.001<0.001
  Never1696 (91.0)1322 (89.1)1197 (81.9) a,b840 (55.0) a,b,c
  Current/Quit168 (9.0)161 (10.9)265 (18.1) a,b686 (45.0) a,b,c
Alcoholic drinking <0.001<0.001
  Never1703 (91.4)1321 (89.1)1284 (87.8) a1212 (79.4) a,b,c
  Current/Quit 161 (8.6)162 (10.9)178 (12.2) a314 (20.6) a,b,c
Betel nut chewing <0.001<0.001
  Never1743 (93.5)1392 (93.9)1334 (91.2) b1230 (80.6) a,b,c
  Current/Quit 121 (6.5)91 (6.1)128 (8.8) b296 (19.4) a,b,c
Intake vegetables <0.001<0.001
  Never/Seldom589 (31.6)464 (31.3)508 (34.7)583 (38.2) a,b
  Often1275 (68.4)1019 (68.7)954 (65.3)943 (61.8) a,b
Intake fruit <0.001<0.001
  Never/Seldom985 (52.8)784 (52.9)811 (55.5)932 (61.1) a,b,c
  Often879 (47.2)699 (47.1)651 (44.5)594 (38.9) a,b,c
Adopt regular exercise <0.001<0.001
  Never/Seldom1211 (65.0)1004 (67.7)1055 (72.2) a,b1122 (73.5) a,b
  Often653 (35.0)479 (32.3)407 (27.8) a,b404 (26.5) a,b
HBsAg275 (14.8)238 (16.0)270 (18.5) a284 (18.6) a0.0050.001
Anti-HCV247 (13.3)214 (14.4)204 (14.0)244 (16.0)0.1470.043
AST > 35 U/L159 (8.5)133 (9.0)148 (10.1)213 (14.0) a,b,c<0.001<0.001
ALT > 35 U/L379 (20.3)291 (19.6)310 (21.2)382 (25.0) a,b0.0010.001
Abbreviations: CRE, Creatinine; BMI, body mass index; 1-OHP, 1-hydroxypyrene; Q, quartile; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; AST, aspartate aminotransferase ; ALT, alanine aminotransferase; 1 Waist circumference, male > 90 cm and female > 80 cm; a, b, and c indicate significant difference as compared to the Q1, Q2, and Q3 groups, respectively, by using Bonferroni post hoc test.
Table 3. Association between the demographic characteristics and the risk of higher level of 1-OHP.
Table 3. Association between the demographic characteristics and the risk of higher level of 1-OHP.
Explanatory VariableTotalFemaleMale
Adjusted OR (95% CI)p-ValueAdjusted OR (95% CI)p-ValueAdjusted OR (95% CI)p-Value
Age, year0.97 (0.96–0.98)<0.0010.97 (0.96–0.98)<0.0010.98 (0.97–0.98)<0.001
Female2.30 (2.06–2.57)<0.001----
Education level, years0.96 (0.95–0.97)<0.0010.96 (0.95–0.98)<0.0010.94 (0.93–0.96)<0.001
Metabolic syndrome1.10 (0.99–1.22)0.0821.05 (0.90–1.21)0.5611.17 (1.00–1.36)0.049
Frequent intake vegetables1.00 (0.90–1.11)0.9901.06 (0.92–1.22)0.4570.97 (0.83–1.13)0.665
Frequent intake fruit0.96 (0.87–1.07)0.4651.02 (0.89–1.16)0.7660.86 (0.73–1.01)0.060
Adopt regular exercise0.93 (0.84–1.03)0.1791.09 (0.95–1.25)0.2370.80 (0.69–0.94)0.005
Smoking6.94 (5.96–8.08)<0.0019.27 (6.46–13.30)<0.0016.01 (5.06–7.15)<0.001
Alcoholic drinking1.16 (0.99–1.36)0.0611.20 (0.82–1.75)0.3471.13 (0.95–1.35)0.162
Betel nut chewing1.25 (1.04–1.52)0.0192.04 (1.01–4.10)0.0461.14 (0.93–1.39)0.204
HBsAg1.27 (1.12–1.43)<0.0011.26 (1.07–1.49)0.0071.30 (1.09–1.55)0.003
Anti-HCV1.43 (1.24–1.64)<0.0011.49 (1.24–1.79)<0.0011.39 (1.11–1.73)0.003
Abbreviations: 1-OHP, 1-hydroxypyrene; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; OR, odds ratio; CI, confidence interval.
Table 4. Factors associated with the quartiles of urine MDA level (N = 6335).
Table 4. Factors associated with the quartiles of urine MDA level (N = 6335).
VariableQ1
(n = 1654)
Q2
(n = 1581)
Q3
(n = 1601)
Q4
(n = 1499)
p-Valuep Trend
Level, μmol/g creatinine≤0.40.4–0.90.9–1.5>1.5
Age, year43.7 ± 15.344.7 ± 15.548.3 ± 15.5 a,b54.4 ± 16.1 a,b,c<0.001<0.001
Female1022 (61.8)839 (53.1) a826 (51.6) a887 (59.2) b,c<0.0010.058
Education level, years10.8 ± 5.510.7 ± 5.59.5 ± 5.6 a,b7.3 ± 6.0 a,b,c<0.001<0.001
Body mass index ≥ 24 kg/m2814 (49.2)833 (52.7)941 (58.8) a,b930 (62.0) a,b<0.001<0.001
Metabolic syndrome (MetS)398 (24.1)433 (27.4)502 (31.4) a576 (38.4) a,b,c<0.001<0.001
No. of MetS components1.51 ± 1.321.63 ± 1.401.81 ± 1.40 a,b2.04 ± 1.40 a,b,c<0.001<0.001
Each component of MetS
  SBP/DBP ≥ 130/85 mmHg818 (49.5)814 (51.5)907 (56.7) a,b929 (62.0) a,b,c<0.001<0.001
  Waist circumference 1607 (36.7)612 (38.7)675 (42.2) a742 (49.5) a,b,c<0.001<0.001
  FBG ≥ 100 mg/dL487 (29.4)499 (31.6)583 (36.4) a,b648 (43.2) a,b,c<0.001<0.001
  HDL-C < 40/50 (M/F) mg/dL153 (9.3)187 (11.8)210 (13.1) a228 (15.2) a,b<0.001<0.001
  Triglyceride ≥ 150 mg/dL258 (15.6)295 (18.7)348 (21.7) a312 (20.8) a<0.001<0.001
Smoking <0.001<0.001
  Never 1400 (84.6)1266 (80.1) a1219 (76.1) a,b1170 (78.1) a
  Current/Quit 254 (15.4)315 (19.9) a382 (23.9) a,b329 (21.9) a
Alcoholic drinking <0.0010.002
  Never1481 (89.5)1385 (87.6)1354 (84.6) a1300 (86.7)
  Current/Quit 173 (10.5)196 (12.4)247 (15.4) a199 (13.3)
Betel nut chewing <0.001<0.001
  Never1543 (93.3)1449 (91.7)1404 (87.7) a,b1303 (86.9) a,b
  Current/Quit 111 (6.7)132 (8.3)197 (12.3) a,b196 (13.1) a,b
Intake vegetables 0.0780.017
  Never/Seldom591 (35.7)552 (34.9)515 (32.2)486 (32.4)
  Often1063 (64.3)1029 (65.1)1086 (67.8)1013 (67.6)
Intake fruit 0.3820.125
  Never/Seldom934 (56.5)894 (56.5)869 (54.3)815 (54.4)
  Often720 (43.5)687 (43.5)732 (45.7)684 (45.6)
Adopt regular exercise 0.0710.018
  Never/Seldom1168 (70.6)1110 (70.2)1115 (69.6)999 (66.6)
  Often486 (29.4)471 (29.8)486 (30.4)500 (33.4)
HBsAg235 (14.2)247 (15.6)299 (18.7) a286 (19.1) a<0.001<0.001
Anti-HCV164 (9.9)153 (9.7)225 (14.1) a,b367 (24.5) a,b,c<0.001<0.001
AST > 35 U/L105 (6.3)134 (8.5)175 (10.9) a239 (15.9) a,b,c<0.001<0.001
ALT > 35 U/L293 (17.7)317 (20.1)377 (23.5) a375 (25.0) a,b<0.001<0.001
Abbreviations: MDA, malondialdehyde; Q, quartile; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; AST, aspartate aminotransferase ; ALT, alanine aminotransferase; 1 Waist circumference, male > 90 cm and female > 80 cm; a, b, and c indicate significant difference as compared to the Q1, Q2, and Q3 groups, respectively, by using Bonferroni post hoc test.
Table 5. Association between the demographics/characteristics and the risk of higher level of MDA.
Table 5. Association between the demographics/characteristics and the risk of higher level of MDA.
Explanatory VariableTotalFemaleMale
Adjusted OR (95% CI)p-ValueAdjusted OR (95% CI)p-ValueAdjusted OR (95% CI)p-Value
Age, year1.02 (1.01–1.02)<0.0011.02 (1.01–1.03)<0.0011.02 (1.01–1.03)<0.001
Female0.99 (0.89–1.10)0.792----
Education level, years0.98 (0.97–0.99)0.0010.99 (0.97–1.01)0.2170.96 (0.94–0.98)<0.001
Metabolic syndrome1.08 (0.98–1.20)0.1291.13 (0.97–1.31)0.1131.06 (0.91–1.22)0.482
Frequent intake vegetables1.08 (0.97–1.19)0.1731.14 (0.99–1.31)0.0741.01 (0.87–1.18)0.884
Frequent intake fruit1.00 (0.91–1.10)0.9940.96 (0.84–1.09)0.5181.05 (0.90–1.22)0.517
Adopt regular exercise1.01 (0.91–1.11)0.9140.98 (0.85–1.12)0.7561.05 (0.90–1.21)0.551
Smoking1.32 (1.15–1.51)<0.0011.30 (0.97–1.74)0.0791.33 (1.14–1.56)<0.001
Alcoholic drinking1.00 (0.86–1.16)0.9561.18 (0.82–1.70)0.3810.96 (0.81–1.14)0.637
Betel nut chewing1.22 (1.02–1.45)0.0291.10 (0.55–2.21)0.7801.23 (1.01–1.49)0.039
HBsAg1.25 (1.11–1.41)<0.0011.25 (1.06–1.47)0.0091.28 (1.08–1.52)0.004
Anti-HCV1.48 (1.29–1.70)<0.0011.43 (1.19–1.72)<0.0011.56 (1.26–1.94)<0.001
Abbreviations: MDA, malondialdehyde; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; OR, odds ratio; CI, confidence interval.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Huang, C.-H.; Huang, T.-J.; Lin, Y.-C.; Lin, C.-N.; Chen, M.-Y. Factors Associated with Urinary 1-Hydroxypyrene and Malondialdehyde among Adults near a Petrochemical Factory: Implications for Sex and Lifestyle Modification. Int. J. Environ. Res. Public Health 2022, 19, 1362. https://doi.org/10.3390/ijerph19031362

AMA Style

Huang C-H, Huang T-J, Lin Y-C, Lin C-N, Chen M-Y. Factors Associated with Urinary 1-Hydroxypyrene and Malondialdehyde among Adults near a Petrochemical Factory: Implications for Sex and Lifestyle Modification. International Journal of Environmental Research and Public Health. 2022; 19(3):1362. https://doi.org/10.3390/ijerph19031362

Chicago/Turabian Style

Huang, Cheng-Hsien, Tung-Jung Huang, Yu-Chih Lin, Chia-Ni Lin, and Mei-Yen Chen. 2022. "Factors Associated with Urinary 1-Hydroxypyrene and Malondialdehyde among Adults near a Petrochemical Factory: Implications for Sex and Lifestyle Modification" International Journal of Environmental Research and Public Health 19, no. 3: 1362. https://doi.org/10.3390/ijerph19031362

APA Style

Huang, C. -H., Huang, T. -J., Lin, Y. -C., Lin, C. -N., & Chen, M. -Y. (2022). Factors Associated with Urinary 1-Hydroxypyrene and Malondialdehyde among Adults near a Petrochemical Factory: Implications for Sex and Lifestyle Modification. International Journal of Environmental Research and Public Health, 19(3), 1362. https://doi.org/10.3390/ijerph19031362

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop